Provides for education and outreach for drug-induced movement disorders by the department of health through the health care and wellness education and outreach program.

This bill aims to enhance education and outreach efforts regarding drug-induced movement disorders, which are side effects caused by certain medications. The New York State Department of Health would implement this initiative through its existing health care and wellness education programs. The goal is to better inform both healthcare providers and the public about these disorders.

Supporters of the bill would highlight its potential to improve patient care by ensuring that healthcare professionals are better informed about the side effects of medications. They would argue that increased awareness can lead to earlier detection and better management of drug-induced movement disorders, ultimately benefiting patients' quality of life.

Critics may argue that the bill represents an unnecessary expansion of government involvement in healthcare education. They might express concerns about the allocation of state resources, suggesting that existing programs are sufficient and that this initiative could divert attention from more pressing health issues.